[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Pages 10803-10805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4885]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-10-09AM]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to [email protected]. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Prevalence Survey of Healthcare Associated Infections (HAIs) and
[[Page 10804]]
Antimicrobial Use in U.S. Acute Care Hospitals--New--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID) (proposed),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval to conduct two surveys to obtain
national estimates of HAI prevalence and antimicrobial use in the
United States. Preventing HAIs is a CDC priority, and an essential step
in reducing the occurrence of HAIs is to accurately estimate the burden
of these infections in U.S. hospitals and to describe the types of HAIs
and their causative organisms, including antimicrobial-resistant
pathogens.
The scope and magnitude of HAIs in the U.S. were last directly
estimated in the 1970s and 1980s by CDC's Study on the Efficacy of
Nosocomial Infection Control (SENIC), in which comprehensive data were
collected from a sample of 338 hospitals; 5% of hospitalized patients
acquired an infection not present at the time of admission. CDC's
current HAI surveillance system, the National Healthcare Safety Network
(NHSN) (OMB Control No. 0920-0666, expiration date 9/30/2012), focuses
instead on device-associated and procedure-associated infections in a
variety of patient locations, and does not receive data on all types of
HAIs to make hospital-wide burden estimates. The purpose of this
information collection request is to assess the magnitude and types of
HAIs and antimicrobial use occurring in all patient populations within
acute care hospitals. This information will be used to inform decisions
made by local and national policy makers and hospital infection control
personnel regarding appropriate targets and strategies for preventing
HAIs and the emergence of antimicrobial-resistant pathogens and
encouraging appropriate antimicrobial use. Such assessments can be
obtained in periodic national prevalence studies, such as those that
have been conducted in several European countries.
CDC proposes to conduct two surveys to collect this data. The first
survey will be a limited roll-out survey and will be conducted in 30
facilities across 10 states in collaboration with state public health
authorities and CDC's Emerging Infections Program (EIP). The survey
will be conducted on a single day in participating facilities.
Infection Control Practitioners in participating facilities, such as
infection control personnel, will collect limited demographic and
clinical information on a sample of eligible inpatients and, on the
same day, EIP site personnel will collect information on HAIs and
antimicrobial use for surveyed patients who are on antimicrobial
therapy at the time of the survey. The second survey will involve 500
facilities across the same 10 states and use the same methodology. As
with the first survey, CDC will collaborate with state public health
authorities and EIP sites.
CDC has made the following assumptions in calculating the response
burden. Infection Control Practitioners will be asked to collect a
minimal amount of data, limited to basic demographic and risk factor/
antimicrobial use information. We anticipate that this data collection
will take 5 minutes per patient. EIP personnel will complete data
collection on antimicrobial use and HAIs. CDC estimates that this data
collection will take approximately 15 minutes per patient.
CDC has assumed an average daily patient census of 250 patients for
each of the 30 participating facilities in Survey 1. An
Infection Control Practitioner (ICP) in his/her own facility will be
asked to review \1/3\ or 33% of this number (250); thus, the ICP would
review 82.5 records (rounded up to 83). This number is estimated to be
the same in each phase of the prevalence survey effort.
EIP Personnel will be reviewing medical records of approximately
40% of all patients surveyed in their EIP site in both surveys
1 and 2. In Survey 1, the total number of
patient records surveyed in each EIP site (assuming 3 facilities in
each EIP site and 83 patient records per site) is 247.5 patient
records. Forty percent of that number (247.5) is 99 patient records or
99 responses per EIP site. In Survey 2, there will be more
facilities participating per EIP site (50 facilities per EIP site for a
total of 500 facilities). Again, CDC assumes 82.5 records surveyed per
site (50 x 82.5) or a total of 4,125 patient records. As above, EIP
personnel in each of the 10 sites will review approximately 40% of the
4,125 patient records per site or 1,650 patient records.
CDC will use the data provided to estimate the prevalence of HAIs
and antimicrobial use across this sample of U.S. hospitals as well as
to estimate the distribution of infection types, causative organisms,
and nature of and rationale for antimicrobial use.
This proposed project supports CDC's Strategic Goal of ``Healthy
Healthcare Settings,'' specifically the objectives to ``Promote
compliance with evidence-based guidelines for preventing, identifying,
and managing disease in healthcare settings'' and ``Prevent adverse
events in patients and healthcare workers in healthcare settings.''
There are no costs to respondents, other than their time to
complete the survey. The total annualized burden for this data
collection is 8,039 hours.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Infection Control Practitioners--Survey 1.............. 30 83 5/60
EIP Personnel--Survey 1................................ 10 99 15/60
Infection Control Practitioners--Survey 2.............. 500 83 5/60
EIP Personnel--Survey 2................................ 10 1,650 15/60
----------------------------------------------------------------------------------------------------------------
[[Page 10805]]
Dated: February 26, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-4885 Filed 3-8-10; 8:45 am]
BILLING CODE 4163-18-P